What is the main purpose of this 8-K filing?

The main purpose of this Form 8-K filing is for Elevance Health (then Anthem, Inc.) to inform the market that its officers will be meeting with securities analysts and investors and will be reaffirming the company's ability to meet its previously stated earnings expectations.

Are there any new financial results or guidance provided in this filing?

No, this filing does not provide new financial results or updated guidance. It serves to confirm management's confidence in meeting the earnings expectations that were issued on February 6, 2002, through a press release and conference call.

What are the key risks mentioned by the company that could affect its performance?

The company identifies several risks that could materially impact its financial performance, including trends in healthcare costs and utilization, the ability to secure sufficient premium rate increases, competitor pricing, increased government regulation of health benefits, significant competitor acquisitions or divestitures, the impact of new prescription drugs and technology, financial strength rating downgrades, litigation, provider contracting, and general economic downturns.

What should investors do based on this filing?

Investors should view this filing as a confirmation of management's confidence in achieving prior earnings guidance. However, they are also urged to review the listed forward-looking risks and consult previous SEC filings (like the IPO prospectus and 10-K/10-Q reports) for a comprehensive understanding of the factors that could affect Elevance Health's business.

ELV 8-K SEC Disclosure — Apr 15, 2002

Summary

Elevance Health, Inc. (formerly Anthem, Inc. as of this filing date) issued this Form 8-K on April 15, 2002, to disclose information regarding upcoming meetings with securities analysts and investors. The primary purpose of these meetings is to reaffirm the company's ability to meet previously issued earnings expectations from a February 6, 2002, press release and conference call. This filing serves as a confirmation to the market that management remains confident in achieving its financial guidance. While the filing doesn't introduce new financial results, it reiterates forward-looking statements and highlights potential risks and uncertainties that could impact future performance. Investors should note that these statements are subject to various factors, including healthcare cost trends, premium rate adjustments, regulatory changes, competitive pressures, and general economic conditions. The company emphasizes that actual results may differ materially from projections and urges readers to consult previous SEC filings for a comprehensive understanding of these risks.

Key Highlights

1Elevance Health (Anthem, Inc.) reaffirms its commitment to meeting earnings expectations previously announced on February 6, 2002.
2Company officers will be meeting with securities analysts and investors during the week ended April 19, 2002.
3The purpose of these meetings is to confirm continued confidence in achieving stated financial guidance.
4The filing includes a list of potential risks and uncertainties that could affect future financial results.
5Key risk factors mentioned include healthcare cost trends, premium rate increases, government regulation, and competitive pricing.
6The company cautions investors against placing undue reliance on forward-looking statements.
7Elevance Health has no obligation to update these forward-looking statements for events or circumstances arising after the report date.

Elevance Health, Inc. 8-K Report (Apr 15, 2002)

Summary

Key Highlights

Frequently Asked Questions